This review summarizes current concepts, controversies, and diagnostic and therapeutic challenges in HFpEF, highlighting the potential for novel informatics platforms to classify subphenotypes for targeted therapies.
No takes yet. Share an insight, caveat, or question.
HFpEF subphenotyping via informatics platforms remains hypothesis-generating; leaves open targeted therapies pending prospective validation.
Zakeri et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: